Large and small launch vehicle companies unite [Now in space]

The Korean launch vehicle Nuriho will be launched for the fourth time in November. Nuriho plans to build technological sophistication through its sixth launch in the future. [Photo = Korea Aerospace Research Institute]



Large and small launch vehicle companies have joined forces to develop future space transportation technology.



Perigee Aerospace (Perigee) signed a memorandum of understanding (MOU) with Hanwha Aerospace on the 26th to establish a cooperative system between the two companies for the development of space transportation technology.



Through this agreement, the two companies plan to share technological and sales capabilities to strengthen space launch vehicle development capabilities and continue strategic cooperation. The Hanwha Aerospace delegation, which visited the Perigee Rocket Development Complex (RDC) in Okcheon, Chungcheongbuk-do, signed the business agreement and toured the development status of the space launch vehicle 'Blue Whale 1 (BW1)' currently under development by Perigee and various research facilities, and discussed the direction of cooperation.



Hanwha Aerospace is the system integration company for the national key launch vehicle 'Nuriho' together with the Korea Aerospace Research Institute starting in 2022. It is participating in the construction of engines and test facilities. The fourth launch of Nuriho is scheduled for November this year.



Perigee's Blue Whale 1. [Photo = Perigee]



In 2024, it was also selected as the private system integration company for the 'next-generation launch vehicle' that will launch the lunar lander in 2032.



Perigee is developing a space launch vehicle based on a liquid methane engine. The 3-ton (t) turbopump-type liquid methane engine developed in-house has also been recognized as a national strategic technology. It is expected that high technological synergy will be created through the collaboration between the two companies.



Perigee, which focuses on the development of small space launch vehicles, has recently achieved results such as the successful vertical takeoff and landing test for launch vehicle reuse. Currently, it plans to test flight verification capabilities through a suborbital test launch vehicle utilizing the upper stage of 'Blue Whale 1'. This launch vehicle will also be launched equipped with a liquid methane engine.



Lee Jun-won, head of Hanwha Aerospace's space business division, said, "Through this agreement, we have established a mutual cooperation system with Perigee," and "We expect to be able to contribute to the growth of the domestic space industry based on the technological capabilities of both companies."



Shin Dong-yoon, CEO of Perigee, said, "Perigee's business expansion will accelerate through cooperation with Hanwha Aerospace, which has long-standing technological expertise in the space industry," and "This cooperation will be an important opportunity to lead Perigee's rapid growth and expand its position as a next-generation private space launch vehicle company."





https://www.inews24.com/view/blogger/1827357

Comments

Post a Comment

Popular posts from this blog

Livestock Manure Methane Is Soaring, But ‘Resource Recovery’ Isn’t Working [Now is a Climate Crisis]

Image
It has been pointed out that the methane emissions from the livestock waste treatment process were actually reported to be 2.5 times smaller than the previous calculation standards. It is expected that livestock waste will increase rapidly in the future, but an analysis report has been released that 'biogasification', which turns it into a resource, is only at the 10% level. It is urgent to come up with countermeasures as methane, one of the greenhouse gases, is expected to increase rapidly. According to the analysis of the entire livestock waste treatment process for the first time in Korea, the largest source of methane emissions was pigs (73%), and only 14% of pig waste was used for biogas in the public sector. It has been pointed out that it is urgent to come up with countermeasures as methane from livestock waste is increasing rapidly but 'resource conversion' is insufficient. [Photo = Climate Solution] About half of domestic methane...
Read more

KT-MS, 'Super Cooperation' to Improve Korea's AI Capabilities... "Providing AI Education to All Citizens" (Comprehensive)

Image
KT and Microsoft (MS) are going beyond corporate partnerships to engage in hyper-collaboration to enhance Korea's artificial intelligence (A)I capabilities. The plan is to provide AI education to all citizens interested in AI and contribute to improving the level of "national AI literacy" (the ability to understand and utilize AI technology). KT CEO Kim Young-seop (left) and Microsoft CEO and Chairman of the Board Satya Nadella pose for a commemorative photo after meeting at KT's Gwanghwamun office on the 25th. [Photo = KT] First official meeting of the two companies' CEOs in Korea···Discussion of plans to promote AX in Korea On the 26th, KT announced that KT CEO Kim Young-seop and Microsoft CEO and Chairman of the Board Satya Nadella met and exchanged opinions on accelerating the industry's AX (AI transition). The explanation is that they discussed agenda items that will help strengthen the country's AI competitivenes...
Read more

After 2030, more powerful anticancer drugs will be available [Science Now]

Image
Postgraduate researcher Jiwoo Choi (first author) is using a pipette tool to transfer blood components into several wells (small containers) to culture them into macrophages [Photo = KRIST] A domestic research team has found a clue to a new anticancer technology that can complement the existing CAR-T anticancer drug. Dr. Jihoon Park's team at the Korea Research Institute of Chemical Technology (President Youngguk Lee) successfully produced CAR-M (Car-M, Car-Macrophage) by stably inserting anticancer genes into macrophages derived from human peripheral blood using lentivirus. It is expected to be applied to the treatment of solid cancers in addition to blood cancers. 'Chimeric antigen receptor (CAR) T cell therapy' is a technology that extracts T cells, which are immune cells, from the body, genetically modifies them to attack specific cancer cells, and then injects them into the patient. It is very effective in treating some blood cancers such as leukemia, b...
Read more